Smart pump system helps toddlers with diabetes – no more guesswork?
NCT ID NCT06017089
First seen Oct 01, 2025 · Last updated May 23, 2026 · Updated 33 times
Summary
This study tested an AI-driven artificial pancreas system in 33 young children (ages 2-6) with type 1 diabetes. The system combined an insulin pump with a continuous glucose monitor and automatically adjusted insulin doses using smart algorithms. Over eight weeks at home, researchers checked if the system was safe and improved blood sugar control compared to the children's usual care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Barbara Davis Center, University of Colorado
Aurora, Colorado, 80045, United States
-
Stanford University
Stanford, California, 94305, United States
-
University of Virginia
Charlottesville, Virginia, 22903, United States
Conditions
Explore the condition pages connected to this study.